Chinese Journal of Nephrology, Dialysis & Transplantation ›› 2019, Vol. 28 ›› Issue (4): 301-306.DOI: 10.3969/j.issn.1006-298X.2019.04.001
• Article • Next Articles
Online:
Published:
Abstract:
Objective:To ananlysis factors that influence hematopoietic recovery after autologous peripheral blood stem cell transplantation (APBSCT) for patients with light chain (AL) amyloidosis. Methodology:211 AL amyloidosis patients who underwent APBSCT in our hospital from July 2010 to June 2018 were included. We retrospectively analysis the baseline characteristics,factors related to the stem cell collection and transplantation process. COX univariate and multivariate regression,logistic regression were used to analysis influencing factors of hematopoietic reconstitution after APBSCT. Results:All patients achieved neutrophil engraftment and the median time to engraftment was 10 (range,8~22) days. COX multivariate analysis showed that pretreatment with highdose melphalan,a hematologic response better than partial relief before transplantation were associated with a rapid neutrophil engraftment. 209 patients achieved platelet engraftment within 100 days of transplantation,and the median time to platelet engraftment was 11 (range,8~31) days. COX multivariate analysis showed that pretreatment with highdose melphalan was related to a higher probability of rapid platelet engraftment. Logistic analysis showed that collecting stem cells>84×106 cells/kg,pretreatment with highdose melphalan may have a positive effect to engraftment,however leukocyte before transplantation less than 40×109/L may be opposite. Conclusion:CD34+ cells,melphalan dose for pretreatment,and pretransplant hematologic response status were important factors influencing hematological reconstruction after APBSCT in AL patients.
Key words: light chain amyloidosis, autologous peripheral blood stem cell transplantation, hematopoietic recovery
CHEN Qinghuo,HUANG Xianghua,ZHAO Liang,et al. Factors influencing engraftment after autologous peripheral blood stem cell transplantation for light chain amyloidosis[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2019, 28(4): 301-306.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.njcndt.com/EN/10.3969/j.issn.1006-298X.2019.04.001
http://www.njcndt.com/EN/Y2019/V28/I4/301